Suchergebnisse - (Person:"Ma, Ling")

PubPharm (23)

1

Clinical laboratory tests and dementia incidence : A prospective cohort study

enthalten in: Journal of affective disorders | 2024

von Huang, Y. | Wang, H. | Wu, B. | +5

2

A multi-functional fluorescent probe for visualization of H2S and viscosity/polarity and its application in cancer imaging

enthalten in: Analytical and bioanalytical chemistry | 2024

von Ma, L. | Zan, Q. | Zhang, B. | +3

3

Dynamic changes of CSF clusterin levels across the Alzheimer's disease continuum

enthalten in: BMC neurology | 2022

von Tang, L. | Wang, Z. | Ma, L. | +3

4

Serum exosomal coronin 1A and dynamin 2 as neural tube defect biomarkers

enthalten in: Journal of molecular medicine (Berlin, Germany) | 2022

von Wang, Y. | Ma, L. | Jia, S. | +8

5

Application of the Amyloid/Tau/Neurodegeneration Framework in Cognitively Intact Adults : The CABLE Study

enthalten in: Annals of neurology | 2022

von Hu, H. | Bi, Y. | Shen, X. | +8

6

sTREM2 mediates the associations of minimal depressive symptoms with amyloid pathology in prodromal Alzheimer's disease : The CABLE study

enthalten in: Translational psychiatry | 2022

von Wang, Z. | Sun, Y. | Ma, Y. | +7

7

Late-Life Obesity Associated with Tau Pathology in Cognitively Normal Individuals : The CABLE Study

enthalten in: Journal of Alzheimer's disease : JAD | 2022

von Zhang, X. | Ma, Y. | Hu, H. | +3

8

Circulating miRNA-1-3p as Biomarker of Accelerated Sarcopenia in Patients Diagnosed with Chronic Heart Failure

enthalten in: Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion | 2022

von Xu, R. | Cui, S. | Chen, L. | +4

9

P-tau and neurodegeneration mediate the effect of β-amyloid on cognition in non-demented elders

enthalten in: Alzheimer's research & therapy | 2021

von Ma, L. | Hu, H. | Wang, Z. | +4

10

P-tau and neurodegeneration mediate the effect of β-amyloid on cognition in non-demented elders

enthalten in: Alzheimer's research & therapy | 2021

von Ma, L. | Hu, H. | Wang, Z. | +4